rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Jacob A. Orville

Senior Vice President

Company insider

Files Form 4 as: Senior Vice President, Abbott Laboratories; EVP, GM, Screening, Exact Sciences.

Every Form 4 they filed

In numbers

Trades disclosed
112
Buys
0
Sells
19
Bought
$0
Sold
$3.3M
Companies
2
Companies where not an officer
0
First trade
14 Feb 2020
Last trade
23 Mar 2026
Last filed
25 Mar 2026

Companies traded

Where they are an officer
Exact SciencesOfficer · Diagnostics & Labs · last 23 Mar 20260 buys · 19 sells
ABT Abbott LaboratoriesOfficer · Biotechnology · last 23 Mar 20260 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
10Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
23 Mar 2026filed 25 Mar 2026ABT Abbott LaboratoriesBiotechnologySEC FORM 4 Code A—13,255 at $0.00filing
23 Mar 2026filed 25 Mar 2026ABT Abbott LaboratoriesBiotechnologySEC FORM 4 Code A—13,255 at $0.00filing
23 Mar 2026filed 23 Mar 2026Exact SciencesDiagnostics & LabsSEC FORM 4 Code A—53,323 at $0.00filing
23 Mar 2026filed 23 Mar 2026Exact SciencesDiagnostics & LabsSEC FORM 4 Code D—153,726filing
23 Mar 2026filed 23 Mar 2026Exact SciencesDiagnostics & LabsSEC FORM 4 Code D—1,774filing
23 Mar 2026filed 23 Mar 2026Exact Sciencesoption or derivativeSEC FORM 4 Code D—6,581filing
23 Mar 2026filed 23 Mar 2026Exact Sciencesoption or derivativeSEC FORM 4 Code D—38,707filing
23 Mar 2026filed 23 Mar 2026Exact Sciencesoption or derivative · Diagnostics & LabsSEC FORM 4 Code D—6,581filing
23 Mar 2026filed 23 Mar 2026Exact Sciencesoption or derivative · Diagnostics & LabsSEC FORM 4 Code D—38,707filing
23 Mar 2026filed 23 Mar 2026Exact SciencesSEC FORM 4 Code A—53,323 at $0.00filing
23 Mar 2026filed 23 Mar 2026Exact SciencesSEC FORM 4 Code D—153,726filing
23 Mar 2026filed 23 Mar 2026Exact SciencesSEC FORM 4 Code D—1,774filing
25 Feb 2026filed 27 Feb 2026Exact Sciencesoption or derivative · Diagnostics & LabsSEC FORM 4 Code A—38,707 at $0.00filing
25 Feb 2026filed 27 Feb 2026Exact Sciencesoption or derivativeSEC FORM 4 Code A—38,707 at $0.00filing
23 Dec 2025filed 30 Dec 2025Exact Sciencesoption or derivativeSEC FORM 4 Code M—3,955 at $0.00filing
23 Dec 2025filed 30 Dec 2025Exact Sciencesoption or derivativeSEC FORM 4 Code M—9,450 at $0.00filing
23 Dec 2025filed 30 Dec 2025Exact Sciencesoption or derivativeSEC FORM 4 Code M—14,845 at $0.00filing
23 Dec 2025filed 30 Dec 2025Exact Sciencesoption or derivativeSEC FORM 4 Code M—28,779 at $0.00filing
23 Dec 2025filed 30 Dec 2025Exact Sciencesoption or derivativeSEC FORM 4 Code M—16,051 at $0.00filing
23 Dec 2025filed 30 Dec 2025Exact SciencesSEC FORM 4 Code M—3,955 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Not placed19

Buys in green, sells in red, by the company’s sector.

Related people

Nita AhujaDirector · Director at Abbott Laboratories, filing Form 4 there in the last year
Michael F. RomanDirector · Director at Abbott Laboratories, filing Form 4 there in the last year
Kevin T. ConroyDirector · Director at Abbott Laboratories, filing Form 4 there in the last year
Patricia Paola GonzalezDirector · Director at Abbott Laboratories, filing Form 4 there in the last year
John G. StrattonDirector · Director at Abbott Laboratories, filing Form 4 there in the last year